01 Communique Provides Update on Business Developments and Third Quarter Fiscal 2023 Results
01 Communique Provides Update on Business Developments and Third Quarter Fiscal 2023 Results
TORONTO, ON / ACCESSWIRE / September 21, 2023 / 01 Communique Laboratory Inc. (the "Company") (TSX-V:ONE; OTCQB:OONEF), one of the first-to-market, enterprise level cybersecurity providers for the quantum computing era, is pleased to report the Company's third quarter fiscal 2023 results, which ended July 31, 2023.
多倫多,2023年9月21日/ACCESSWIRE/01公報實驗室公司(以下簡稱“公司”)(多倫多證券交易所股票代碼:ONE;OTCQB:ONEF)是量子計算時代首批上市的企業級網路安全提供商之一,該公司高興地報告了截至2023年7月31日的2023財年第三季度業績。
Andrew Cheung, CEO of the Company, commented, "Global recognition of threat from quantum computers has never been higher. Following through with their recommendation in July 2022, the National Institute of Standards and Technologies (NIST) published 3 standards of Post-Quantum Cryptography (PQC) algorithms on Aug 24 last month (FIPS 203, FIPS 204, and FIPS 205). Lockstep with NIST's progress, these standards are already part of our IronCAP Toolkits. Being the forerunner in building practical PQC applications such as quantum-safe email security, quantum-safe blockchain, quantum-safe remote access, etc., I am confident that IronCAP will add significant value to help our partners to provide enhanced security against bad actors using Quantum Computers,"
該公司首席執行官安德魯·張評論說:“全球對量子電腦威脅的認知度從未像現在這樣高。為了貫徹他們在2022年7月提出的建議,美國國家標準與技術研究所(NIST)於上個月8月24日發佈了3個後量子密碼(PQC)算法標準(FIPS 203、FIPS 204和FIPS 205)。與NIST的進展同步,這些標準已經成為我們IronCap工具包的一部分。作為構建量子安全電子郵件安全、量子安全區塊鏈、量子安全遠端訪問等實用PQC應用程式的先行者,我相信IronCap將增加重大價值,幫助我們的合作夥伴使用Quantum Computers提供增強的安全性,以抵禦不良行為者。
Andrew Cheung continued, "As announced during our last quarterly results, with the major portion of our development efforts having been completed we expect a reduction in our operating expenses and switching focus on integrating applications and features enhancements for our partners. This is clearly reflected in our Q3 results with a new partner signing up and a significant reduction on our quarterly loss. We expect this trend to continue in upcoming quarters."
張建宗繼續說:“正如我們在上個季度業績中宣佈的那樣,隨著我們的大部分開發工作已經完成,我們預計我們的運營費用將減少,並將重點轉移到為我們的合作夥伴集成應用程式和功能增強上。這清楚地反映在我們第三季度的業績中,新合作夥伴簽約,我們的季度虧損顯著減少。我們預計這一趨勢將在未來幾個季度繼續下去。”
Operational Highlights:
運營要點:
- As announced on July 10, 2023 we entered into a partnership with Keyfactor, the identity-first security solution for modern enterprises. Our partnership fosters the development, in conjunction with joint marketing, of quantum-safe X.509 certificates for the Enterprise Certification Authority solution (EJBCA) as well as cybersecurity solutions for global businesses, organizations, and governments to help them achieve cyber resilience.
- On June 6th our quantum-safe blockchain endpoints protection patent was officially issued in the US. The US patent # is 11,669,833 and can be found on the USPTO site.
- We have received a notice of allowance for our Japanese patent application #2020-534978 about the IronCAP Modern McEliece code-based post-quantum cryptography technology. Official patent issuance is in the process.
- Earlier in fiscal 2023 we completed integrating IronCAP into one of our partners' military-grade Hardware Security Modules ("HSM') making post quantum cryptography functionality seamless. Joint-marketing activities have been in process since April 2023 beginning with our participation at the RSA Conference held in San Francisco as part of our partner's PQC Palooza event where together we promoted post-quantum cryptography to enterprise customers. Throughout the third quarter other activities have taken place which have been very encouraging with expectations of more partnerships on the horizon.
- As announced on June 14th we released IronCAP X v2.0, which we believe to be the world's first commercially available quantum-safe end-to-end email security product for enterprises of all sizes.
- Global partners have been signed and integration efforts have begun with the goal to capitalize on the quantum-readiness transformation market embraced by enterprises of all sizes internationally.
- 正如2023年7月10日宣佈的那樣,我們與面向現代企業的身分優先安全解決方案Keyfactor達成了合作夥伴關係。我們的合作夥伴關係結合聯合營銷,促進為企業認證機構解決方案(EJBCA)開發量子安全X.509證書,以及為全球企業、組織和政府提供網路安全解決方案,以幫助他們實現網路彈性。
- 6月6日這是我們的量子安全區塊鏈端點保護專利在美國正式發佈。美國專利號為11,669,833號,可在USPTO網站上找到。
- 我們已經收到了日本專利申請#2020-534978的許可通知,該專利申請涉及基於IronCap現代麥克利希代碼的後量子加密技術。官方的專利發佈正在進行中。
- 早在2023財年,我們就完成了將IronCap集成到我們的一個合作夥伴的軍用級硬體安全模塊(HSM)中,使後量子加密功能無縫。自2023年4月以來,我們一直在進行聯合營銷活動,首先是我們參加了在舊金山舉行的RSA會議,這是我們合作夥伴PQC Palooza活動的一部分,我們在會上共同向企業客戶推廣後量子加密。整個第三季度還開展了其他活動,這些活動非常令人鼓舞,預計將有更多的合作夥伴。
- 6月14日宣佈的這是我們發佈了IronCap X v2.0,我們相信這是世界上第一款面向各種規模企業的商用量子安全端到端電子郵件安全產品。
- 已經簽署了全球合作夥伴,並開始了整合努力,目標是利用國際上各種規模的企業所擁抱的量子就緒轉型市場。
Financial Highlights:
財務亮點:
- Revenue for the third quarter was $106,197 (2022 - $236,002) a $129,805 decrease. Royalty revenue remained fairly steady quarter over quarter. Royalties are received from the Company's remote access business which is marketed on a subscription fee basis with recurring royalties. The overall decrease in revenue is a result of one time development fees recognized in 2022 for the completed portion of a Quantum-Safe Blockchain project.
- The loss for the third quarter was $119,652 (2022 - $190,242). The adjusted loss excluding stock-based compensation and depreciation which are non-cash expenses, for the second quarter was $73,998 (2022 - $135,374) a reduction of $61,376. The Company completed the quarter with $370,360 of cash and a GIC.
- Cash operating expenses which exclude stock-based compensation and depreciation for the third quarter were $173,395 (2022 - $361,036) a reduction of $187,036 primarily the result of:
- Completion of a number of R&D projects which included enhancements to the Company's remote access product, integration of IronCAP into the Company's partners' HSM, and the integration of IronCAPTM into existing public blockchains has contributed to the reduction in development expenses for fiscal 2023.
- Contributing factors to the lower selling, general and administrative expenses included costs incurred in fiscal 2022 for non-recurring legal expenses pertaining to the prosecution of patent applications including the patent received in fiscal 2023 as well as investor relations campaigns that were completed in fiscal 2022.
- As a result, the Company has been able to reduce cash operating expenses with a goal to keep them in line with the ongoing recurring revenue.
- 第三季度營收為106,197美元(2022-236,002美元),較上年同期減少129,805美元。特許權使用費收入季度環比保持相當穩定。特許權使用費來自公司的遠端訪問業務,該業務以訂閱費為基礎進行營銷,並有經常性的特許權使用費。收入的總體下降是2022年為量子安全區塊鏈專案的完成部分確認的一次性開發費用的結果。
- 第三季度虧損119,652美元(2022-190,242美元)。第二季度不包括基於股票的補償和非現金支出的折舊的調整後虧損為73,998美元(2022-135,374美元),減少61,376美元。該公司在本季度結束時擁有370,360美元現金和一個GIC。
- 第三季度不包括股票薪酬和折舊的現金運營費用為173,395美元(2022-361,036美元),減少187,036美元,主要原因是:
- 完成一些研發專案,其中包括對公司遠端訪問產品的改進,將IronCap整合到公司合作夥伴的HSM中,以及整合IronCapTM整合到現有公共區塊鏈中,有助於減少2023財年的開發費用。
- 銷售、一般和行政費用較低的原因包括2022財年與起訴專利申請(包括2023財年收到的專利)有關的非經常性法律費用以及2022財年完成的投資者關係活動的成本。
- 因此,該公司能夠減少現金運營費用,目標是使其與持續的經常性收入保持一致。
Grant of Stock Options
授予股票期權
The Company granted stock options pursuant to its stock option plan to directors and executives of the Company to purchase up to an aggregate of 1,240,000 common shares in the Company. The options were granted on September 20, 2023 and are exercisable at a price of $0.12 per share for a period of four years from the date of grant. The options vest over a period of two years, with 25% vesting on each of March 20, 2024, September 20, 2024, March 20, 2025 and September 20, 2025. The options, and the shares issuable upon exercise, will be subject to applicable securities and regulatory laws. After granting these stock options, there will be a total of 6,365,000 options outstanding under the stock option plan.
公司根據其股票期權計劃向公司董事和高管授予股票期權,以購買最多1,240,000股公司普通股。這些期權於2023年9月20日授予,可在授予之日起四年內以每股0.12美元的價格行使。期權在兩年內歸屬,2024年3月20日、2024年9月20日、2025年3月20日和2025年9月20日各歸屬25%。期權和行使時可發行的股票將受到適用的證券和監管法律的約束。在授予這些股票期權後,根據股票期權計劃,將有總計6,365,000份未償還期權。
Conference Call Reminder and Information:
電話會議提醒和資訊:
01 Communique will host a live teleconference allowing for questions and answers later today at 10:00AM EST (September 21, 2023) to discuss the Company's results as well as providing an update on the business prospects for IronCAP and IronCAP X.
01公報將在美國東部時間今天晚些時候(2023年9月21日)上午10:00主持一次現場電話會議,允許提問和回答,討論公司的業績,並提供IronCap和IronCap X的最新業務前景。
Browser (please cut-and-paste the following link into your browser):
瀏覽器(請將以下鏈接剪切並黏貼到您的瀏覽器中):
Passcode: ironcap23
密碼:ironcap23
Dial-in:
Within Canada (647) 374-4685 or (647) 558-0588
Within the USA (646) 558 8656 or (669) 900-9128
Webinar ID when prompted is 832 7263 0612
撥入:
加拿大國內(647)374-4685或(647)558-0588
在美國境內(646)558 8656或(669)900-9128
提示時的網路研討會ID為832 7263 0612
Passcode: 286832739
密碼:286832739
About 01 Communique
關於01公報
Established in 1992, 01 Communique (TSX-V: ONE; OTCQB: OONEF) has always been at the forefront of technology. The Company's cyber security business unit focuses on post-quantum cybersecurity with the development of its IronCAP product line. IronCAP's technologies are patent-protected in the U.S.A. by its patents #11,271,715 and #11,669,833. The Company's remote access business unit provides its customers with a suite of secure remote access services and products under its I'm InTouch and I'm OnCall product offerings. The remote access offerings are protected in the U.S.A. by its patents #6,928,479 / #6,938,076 / #8,234,701; in Canada by its patents #2,309,398 / #2,524,039 and in Japan by its patent #4,875,094. For more information, visit the Company's web site at and .
成立於1992年的01公報(多倫多證券交易所股票代碼:ONE;OTCQB:OONEF)一直走在技術的前沿。隨著Ironcapp產品線的發展,公司的網路安全業務部門專注於後量子網路安全。鐵帽的技術在美國受專利#11,271,715和#11,669,833保護。公司的遠端訪問業務部門根據I‘m InTouch和I’m OnCall產品為客戶提供一套安全的遠端訪問服務和產品。遠端訪問產品在美國受專利#6,928,479/#6,938,076/#8,234,701保護;在加拿大受專利#2,309,398/#2,524,039保護;在日本受專利#4,875,094保護。有關更多資訊,請訪問公司的網站和。
Cautionary Note Regarding Forward-looking Statements.
有關前瞻性陳述的注意事項。
Certain statements in this news release may constitute "forward-looking" statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. When used in this news release, such statements use such words as "may", "will", "expect", "believe", "plan", "intend", "are confident" and other similar terminology. Such statements include statements regarding the commercial success of IronCAP X, the future of quantum computers and their impact on the Company's product offering, the functionality of the Company's products and the intended product lines for the Company's technology and the potential licensing of the Company's technology. These statements reflect current expectations regarding future events and operating performance and speak only as of the date of this news release. Forward-looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements, including, but not limited to, the factors discussed under "Risk and Uncertainties" in the Company's Management`s Discussion and Analysis document filed on SEDAR. Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release, and the Company assumes no obligation to update or revise them to reflect new events or circumstances.
本新聞稿中的某些陳述可能構成“前瞻性”陳述,涉及已知和未知的風險、不確定因素和其他因素,這些風險、不確定性和其他因素可能導致公司的實際結果、業績或成就或行業結果與此類前瞻性陳述明示或暗示的任何未來結果、業績或成就大不相同。在本新聞稿中使用時,此類聲明使用了諸如“可能”、“將”、“期望”、“相信”、“計劃”、“打算”、“有信心”等詞語和其他類似術語。這些陳述包括有關IronCap X的商業成功、量子電腦的未來及其對公司產品供應的影響、公司產品的功能和公司技術的預定產品線以及公司技術的潛在許可的陳述。這些陳述反映了目前對未來事件和經營業績的預期,僅代表截至本新聞稿發佈之日的情況。前瞻性陳述涉及重大風險和不確定性,不應被解讀為對未來業績或結果的保證,也不一定是對是否會實現此類結果的準確指示。許多因素可能導致實際結果與前瞻性陳述中討論的結果大相徑庭,包括但不限於,在公司提交給SEDAR的公司管理層討論和分析檔案中“風險和不確定因素”項下討論的因素。儘管本新聞稿中包含的前瞻性陳述是基於公司管理層認為合理的假設,但公司不能向投資者保證實際結果將與這些前瞻性陳述一致。這些前瞻性陳述是截至本新聞稿發佈之日作出的,公司沒有義務更新或修改這些陳述以反映新的事件或情況。
Neither TSX Venture Exchange ("TSX-V") nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
多倫多證券交易所創業板交易所(“多倫多證券交易所”)及其監管服務提供商(該術語在多倫多證券交易所創業板政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
INVESTOR CONTACT:
Brian Stringer
Chief Financial Officer
01 Communique
(905) 795-2888 x204
Brian.stringer@01com.com
投資者聯繫方式:
布萊恩·斯特林格
首席財務官
01公報
(905)795-2888 x204
郵箱:Brian.stringer@01com.com
01 Communique Laboratory Inc. SELECTED FINANCIAL INFORMATION Consolidated Statements of Financial Position Unaudited | ||||
As at July 31, 2023 and October 31, 2022 | ||||
31-July-23 | 31-Oct-22 | |||
Assets |
||||
Current assets |
||||
Cash and cash equivalents |
$ | 290,360 | $ | 487,179 |
Guaranteed investment certificate |
80,000 | 150,000 | ||
Accounts receivable |
89,431 | 316,270 | ||
Prepaid expenses and other assets |
42,385 | 64,131 | ||
502,176 | 1,017,580 | |||
Plant and equipment |
51,156 | 90,911 | ||
Investment |
1,500 | 1,500 | ||
Total assets |
$ | 554,832 | $ | 1,109,991 |
Liabilities and Shareholders' Deficit |
||||
Current liabilities |
||||
Accounts payable |
$ | 75,194 | $ | 272,784 |
Deferred revenue |
5,324 | 5,487 | ||
Lease liability |
32,230 | 46,349 | ||
Canadian emergency business loan |
40,000 | - | ||
152,748 | 364,620 | |||
Non-current liabilities |
||||
Lease liability |
- | 20,517 | ||
Canadian emergency business loan |
- | 40,000 | ||
Total liabilities |
152,748 | 385,137 | ||
Shareholders' deficit |
||||
Share capital |
44,282,090 | 44,214,590 | ||
Contributed surplus |
6,247,532 | 6,083,350 | ||
Warrants |
16,875 | 16,875 | ||
Deficit |
(50,144,413) | (49,589,961) | ||
402,084 | 724,854 | |||
Total liabilities and shareholders' deficit |
$ | 554,832 | $ | 1,109,991 |
01公報實驗室公司 精選財務資訊 合併財務狀況表 未經審計 | ||||
截至2023年7月31日和2022年10月31日 | ||||
7月31日至23日 | 10月31日至22日 | |||
資產 |
||||
流動資產 |
||||
現金和現金等價物 |
$ | 290,360 | $ | 487,179 |
保證投資憑證 |
8萬 | 150,000 | ||
應收賬款 |
89,431 | 316,270 | ||
預付費用和其他資產 |
42,385 | 64,131 | ||
502,176 | 1017,580 | |||
廠房和設備 |
51,156 | 90,911 | ||
投資 |
1,500 | 1,500 | ||
總資產 |
$ | 554,832 | $ | 1109,991 |
負債和股東虧損 |
||||
流動負債 |
||||
應付帳款 |
$ | 75,194 | $ | 272,784 |
遞延收入 |
5324 | 5487 | ||
租賃責任 |
32,230 | 46,349 | ||
加拿大緊急商業貸款 |
4萬 | - | ||
152,748 | 364,620 | |||
非流動負債 |
||||
租賃責任 |
- | 20,517 | ||
加拿大緊急商業貸款 |
- | 4萬 | ||
總負債 |
152,748 | 385,137 | ||
股東虧損 |
||||
股本 |
44,282,090 | 44,214,590 | ||
繳款盈餘 |
6247,532 | 6083,350 | ||
認股權證 |
16,875 | 16,875 | ||
赤字 |
(50,144,413) | (49,589,961) | ||
402,084 | 724,854 | |||
總負債和股東赤字 |
$ | 554,832 | $ | 1109,991 |
01 Communique Laboratory Inc. | |||||||||
three months ended | nine months ended | ||||||||
31-Jul-23 | 31-Jul-22 | 31-Jul-23 | 31-Jul-22 | ||||||
Revenue |
$ | 106,197 | $ | 236,002 | $ | 340,782 | $ | 782,627 | |
Expenses: |
|||||||||
Selling, general and administrative |
145,054 | 221,772 | 530,407 | 650,056 | |||||
Research and development |
73,995 | 194,132 | 339,990 | 559,893 | |||||
Withholding taxes |
10,220 | 10,400 | 32,865 | 51,523 | |||||
229,269 | 426,304 | 903,262 | 1,261,472 | ||||||
Loss before other income and expense |
(123,072) | (190,302) | (562,480) | (478,845) | |||||
Interest income |
3,925 | 1,125 | 10,267 | 1,770 | |||||
Interest expense |
(505) | 1,065 | (2,239) | 3,687 | |||||
Loss for the period and comprehensive loss |
$ | (119,652) | $ | (190,242) | $ | (554,452) | $ | (480,762) | |
Loss per common share |
|||||||||
Basic |
$ | (0.00) | $ | (0.00) | $ | (0.01) | $ | (0.01) | |
Diluted |
$ | (0.00) | $ | (0.00) | $ | (0.01) | $ | (0.01) | |
Weighted average number of common shares |
|||||||||
Basic |
96,101,646 | 94,916,728 | 96,101,646 | 94,607,495 | |||||
Diluted |
96,101,646 | 94,916,728 | 96,101,646 | 94,607,495 |
01公報實驗室公司 | |||||||||
截至三個月 | 九個月結束 | ||||||||
7月31日至23日 | 7月31日至22日 | 7月31日至23日 | 7月31日至22日 | ||||||
收入 |
$ | 106,197 | $ | 236,002 | $ | 340,782 | $ | 782,627 | |
費用: |
|||||||||
銷售、一般和行政 |
145,054 | 221,772 | 530,407 | 650,056 | |||||
研發 |
73,995 | 194,132 | 339,990 | 559,893 | |||||
預提稅金 |
10,220 | 10,400 | 32,865 | 51,523 | |||||
229,269 | 426,304 | 903,262 | 1261,472 | ||||||
扣除其他收入和費用前的虧損 |
(123,072) | (190,302) | (562,480) | (478,845) | |||||
利息收入 |
3925 | 1,125 | 10,267 | 1,770 | |||||
利息支出 |
(505) | 1,065 | (2239) | 3687 | |||||
本期損失和綜合損失 |
$ | (119,652) | $ | (190,242) | $ | (554,452) | $ | (480,762) | |
普通股每股虧損 |
|||||||||
基本資訊 |
$ | (0.00) | $ | (0.00) | $ | (0.01) | $ | (0.01) | |
稀釋 |
$ | (0.00) | $ | (0.00) | $ | (0.01) | $ | (0.01) | |
普通股加權平均數 |
|||||||||
基本資訊 |
96,101,646 | 94,916,728 | 96,101,646 | 94,607,495 | |||||
稀釋 |
96,101,646 | 94,916,728 | 96,101,646 | 94,607,495 |
01 Communique Laboratory Inc. SELECTED FINANCIAL INFORMATION |
Consolidated Statements of Cash Flows Unaudited |
For the 3 and 9 month periods ended July 31, 2023 and 2022 |
01公報實驗室公司 精選財務資訊 |
合併現金流量表 未經審計 |
截至2023年和2022年7月31日止的3個月和9個月期間 |
three months ended | nine months ended | ||||||||
31-Jul-23 | 31-Jul-22 | 31-Jul-23 | 31-Jul-22 | ||||||
Cash provided by (used in): |
|||||||||
Operating activities: |
|||||||||
Loss and comprehensive loss for the period |
$ | (119,652) | $ | (190,242) | $ | (554,452) | $ | (480,762) | |
Adjustments to reconcile loss for the period to net cash flows from operating activities: |
|||||||||
Depreciation of property and equipment |
2,354 | 1,086 | 7,286 | 5,111 | |||||
Amortization of right-of-use asset |
11,220 | 11,398 | 33,658 | 33,836 | |||||
Stock-based compensation expense |
43,300 | 53,782 | 164,182 | 141,607 | |||||
Change in non-cash working capital |
8,911 | 43,660 | 50,832 | 143,102 | |||||
(53,867) | (80,316) | (298,494) | (157,106) | ||||||
Financing activities: |
|||||||||
Exercise of stock options |
- | 14,000 | - | 14,000 | |||||
Exercise of warrants |
- | 86,850 | - | 86,850 | |||||
Proceeds from private placement |
- | - | 67,500 | - | |||||
Lease payments made |
(11,113) | (11,279) | (34,637) | (32,866) | |||||
(11,113) | 89,571 | 32,863 | 67,984 | ||||||
Investing activities: |
|||||||||
Proceeds from guaranteed investment certificate |
40,000 | - | 70,000 | - | |||||
Investment |
- | - | - | (31,500) | |||||
Purchase of property and equipment |
(848) | (80) | (1,188) | (15,752) | |||||
39,152 | (80) | 68,812 | (47,252) | ||||||
Decrease in cash |
(25,828) | 9,175 | (196,819) | (136,374) | |||||
Cash, beginning of period |
316,188 | 849,375 | 487,179 | 994,924 | |||||
Cash, end of period |
$ | 290,360 | $ | 858,550 | $ | 290,360 | $ | 858,550 |
截至三個月 | 九個月結束 | ||||||||
7月31日至23日 | 7月31日至22日 | 7月31日至23日 | 7月31日至22日 | ||||||
現金提供方(使用於): |
|||||||||
經營活動: |
|||||||||
本期損失和綜合損失 |
$ | (119,652) | $ | (190,242) | $ | (554,452) | $ | (480,762) | |
對當期虧損與經營活動現金流量淨額進行的調整: |
|||||||||
財產和設備折舊 |
2354 | 1,086 | 7286 | 5,111 | |||||
使用權資產攤銷 |
11,220 | 11,398 | 33,658 | 33,836 | |||||
基於股票的薪酬費用 |
43,300 | 53,782 | 164,182 | 141,607 | |||||
非現金營運資金變動 |
8911 | 43,660 | 50,832 | 143,102 | |||||
(53,867) | (80316) | (298,494) | (157,106) | ||||||
融資活動: |
|||||||||
股票期權的行使 |
- | 14,000 | - | 14,000 | |||||
認股權證的行使 |
- | 86,850 | - | 86,850 | |||||
私募收益 |
- | - | 67,500 | - | |||||
已支付的租賃款項 |
(11,113) | (11,279) | (34,637) | (32,866) | |||||
(11,113) | 89,571 | 32,863 | 67,984 | ||||||
投資活動: |
|||||||||
擔保投資憑證所得收益 |
4萬 | - | 7萬 | - | |||||
投資 |
- | - | - | (31,500) | |||||
購置財產和設備 |
(848) | (80) | (1,188) | (15,752) | |||||
39,152 | (80) | 68,812 | (47252) | ||||||
現金減少 |
(25828) | 9175 | (196,819) | (136,374) | |||||
期初現金 |
316,188 | 849,375 | 487,179 | 994,924 | |||||
期末現金 |
$ | 290,360 | $ | 858,550 | $ | 290,360 | $ | 858,550 |
SOURCE: 01 Communique Laboratory, Inc.
資料來源:01公報實驗室公司